Addressing unmet treatment needs in lupus/lupus nephritis: new depths in B cell targeting

Join our expert faculty in this engaging session, in which we explored the role of B cells and B cell-targeting therapies in the management of SLE/LN.

CME/CPD: Continuing Medical Education/Continuing Professional Development; LN: lupus nephritis; SLE: systemic lupus erythematosus; UK: United Kingdom; US: United States of America.
This symposium and its recording are intended for healthcare professionals (HCPs) only.
This symposium and its recording are not intended for delegates from the US or UK.
This session was not included in the main event CME/CPD credits.
Funded and organized by Novartis Pharma AG, CH-4056 Basel, Switzerland.